Canaccord Genuity

Canaccord Genuity appears on the underwriting syndicate of 2 special purpose acquisition company IPOs in our index, including Velocity Acquisition Corp. and GreenLight Biosciences Holdings, PBC. The full list, with the role credited on each cover page, is in the mandates table on this page.

Canaccord Genuity was credited as a book-running manager on 1 of its 2 SPAC mandates, 50% of them. The remainder are co-manager or syndicate positions, where the economics and the sponsor relationship sit elsewhere.

$437M of gross proceeds across every offering Canaccord Genuity was named on. That is the conventional league-table measure, which credits the full deal to each syndicate member. The narrower figure is its own allocation: $80.0M, being the units the underwriting agreements assigned to Canaccord Genuity specifically, priced at the $10 standard SPAC unit.

Velocity Acquisition Corp., which raised $230M in Feb 2021. Canaccord Genuity was credited as a syndicate member on that offering.

2 of the SPACs Canaccord Genuity underwrote closed a combination: Velocity Acquisition Corp. and GreenLight Biosciences Holdings, PBC. Closing means the vehicle filed a current report reporting completion of the acquisition. That is an outcome, not a return.

Canaccord Genuity has no live SPAC mandates in our index; every vehicle it underwrote has either closed a deal or wound up.

100%. Of the 2 vehicles Canaccord Genuity underwrote that have already resolved, 2 closed a business combination and 0 liquidated. The market-wide figure is 59.5%, so Canaccord Genuity sits above it. SPACs still searching are excluded, because an unfinished clock is not a result. The rate measures the vehicles, not the bank: a syndicate has no control over whether a sponsor finds a target.

We hold a current quote for none of Canaccord Genuity's closed deals, so no comparison is possible here. Post-merger price history is not part of our dataset, and we would rather say so than imply a ranking the data does not support. What this page does show is the outcome of every vehicle and the trust economics disclosed at the time.

GreenLight Biosciences Holdings, PBC (1 deal) and Velocity (1 deal). Sponsor franchises are resolved from the sponsor entity named in each prospectus, so repeat issuers group together even though every vehicle is a separate legal entity.

Most often Citigroup (1) and Roth Capital Partners (1). Syndicate composition is read from the prospectus cover and the underwriting section, so these are co-appearances on the same offering, not a commercial relationship we have any other visibility into.

Its first SPAC IPO in our index priced Jan 15, 2021 and the most recent Feb 24, 2021. It has no live vehicles at present.

The average offering it has been named on raised $219M, against a range from $207M to $230M. Deal size is a reasonable proxy for where a house sits in the market: the bulge bracket concentrates on larger trusts, the SPAC specialists on smaller ones.

Generalist (1), Technology (1) and Energy Transition (1). Mandates are read from charter language in the prospectus and are often deliberately broad. Many SPACs reserve the right to pursue any industry, in which case no sector is tagged at all.

None in our index. Either its vehicles closed a deal or they are still inside their combination window.

Every figure is read from filings the registrants made with the SEC. Syndicate membership and role come from the prospectus cover and the underwriting section of each IPO prospectus (Form 424B4); outcomes come from the filing record: a current report announcing completion, or a delisting notice ending a liquidation. Nothing here is sourced from press coverage or from Canaccord Genuity itself.